Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,301 | 518 | 92.7% |
| Education | $814.24 | 12 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,455 | 67 | $0 (2024) |
| GENZYME CORPORATION | $1,242 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $877.38 | 52 | $0 (2024) |
| PFIZER INC. | $760.98 | 45 | $0 (2024) |
| ABBVIE INC. | $724.46 | 45 | $0 (2024) |
| LEO Pharma Inc. | $642.17 | 30 | $0 (2024) |
| Galderma Laboratories, L.P. | $604.30 | 41 | $0 (2024) |
| Dermavant Sciences, Inc. | $548.81 | 17 | $0 (2024) |
| Amgen Inc. | $512.86 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $418.97 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,971 | 129 | GENZYME CORPORATION ($726.92) |
| 2023 | $2,899 | 119 | Janssen Biotech, Inc. ($445.95) |
| 2022 | $1,725 | 80 | Janssen Biotech, Inc. ($284.91) |
| 2021 | $648.69 | 35 | Janssen Biotech, Inc. ($163.90) |
| 2020 | $203.11 | 13 | Novartis Pharmaceuticals Corporation ($57.61) |
| 2019 | $918.31 | 43 | Novartis Pharmaceuticals Corporation ($222.37) |
| 2018 | $997.55 | 68 | PFIZER INC. ($239.93) |
| 2017 | $753.13 | 43 | Celgene Corporation ($196.80) |
All Payment Transactions
530 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.61 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.64 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.01 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $149.10 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Immunology | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.82 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Immunology | ||||||
| 10/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.35 | General |
| Category: Immunology | ||||||
| 10/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,649 | 5,510 | $346,979 | $202,967 |
| 2022 | 13 | 1,709 | 5,595 | $333,165 | $193,359 |
| 2021 | 16 | 1,952 | 6,848 | $390,189 | $230,914 |
| 2020 | 14 | 1,742 | 4,295 | $263,415 | $110,209 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 829 | $116,060 | $78,258 | 67.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 242 | 1,047 | $99,465 | $52,728 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 238 | 630 | $63,000 | $41,642 | 66.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 211 | 785 | $15,700 | $7,941 | 50.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $11,000 | $6,635 | 60.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 45 | 46 | $7,590 | $4,311 | 56.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 57 | 106 | $8,480 | $3,952 | 46.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 30 | 42 | $6,110 | $3,431 | 56.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $4,760 | $2,368 | 49.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 295 | 1,262 | $10,096 | $951.78 | 9.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 164 | 674 | $4,718 | $748.56 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 315 | 912 | $91,200 | $59,326 | 65.0% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 254 | 1,113 | $105,735 | $56,612 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 233 | 471 | $65,940 | $45,146 | 68.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 212 | 805 | $16,100 | $8,343 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $13,600 | $8,252 | 60.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 54 | 99 | $7,920 | $3,960 | 50.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 43 | 44 | $7,260 | $3,874 | 53.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $4,340 | $2,611 | 60.2% |
| 10040 | Acne surgery | Office | 2022 | 13 | 18 | $2,610 | $1,627 | 62.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 15 | 15 | $2,175 | $1,247 | 57.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 303 | 1,336 | $10,688 | $1,071 | 10.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 156 | 671 | $4,697 | $823.97 | 17.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $900.00 | $466.20 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 362 | 1,061 | $105,480 | $75,931 | 72.0% |
About Dr. Karen Heidelberg, M.D
Dr. Karen Heidelberg, M.D is a Dermatology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467406439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Heidelberg, M.D has received a total of $11,115 in payments from pharmaceutical and medical device companies, with $2,971 received in 2024. These payments were reported across 530 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,301).
As a Medicare-enrolled provider, Heidelberg has provided services to 7,052 Medicare beneficiaries, totaling 22,248 services with total Medicare billing of $737,448. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Detroit, MI
- Active Since 05/22/2006
- Last Updated 05/19/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1467406439
Products in Payments
- DUPIXENT (Biological) $1,579
- TREMFYA (Drug) $1,067
- Otezla (Drug) $752.79
- EUCRISA (Drug) $718.62
- COSENTYX (Biological) $682.74
- VTAMA (Drug) $548.81
- ADBRY (Biological) $489.78
- Sotyktu (Drug) $396.90
- RINVOQ (Biological) $377.86
- TALTZ (Drug) $250.22
- OPZELURA (Drug) $244.33
- REMICADE (Biological) $228.88
- SKYRIZI (Biological) $227.16
- ORACEA (Drug) $191.03
- COSENTYX (Drug) $164.34
- EPIDUO FORTE (Drug) $157.66
- Cabtreo (Drug) $154.17
- Tremfya (Drug) $143.34
- SOOLANTRA (Drug) $139.69
- Enbrel (Biological) $134.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Detroit
David Ozog, M.d, M.D
Dermatology — Payments: $28,730
Dr. Richard Huggins, M.d, M.D
Dermatology — Payments: $10,683
Dr. Tina Pickett Baisden, Md, MD
Dermatology — Payments: $8,752
Dr. Emily Keimig, M.d, M.D
Dermatology — Payments: $7,939
Dr. Snehal Desai, M.d, M.D
Dermatology — Payments: $7,297
Leah Cardwell, M.d, M.D
Dermatology — Payments: $5,220